Ad Theeuwes

Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults

M. Hohenboken, Daphne C Sawlwin, E. Versage, 2021, Vaccines.